News | October 22, 2025
ACG to invest $200 million in US hard-shell capsule manufacturing
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
The combination is approved for advanced endometrial carcinoma that is pMMR or not MSI-H and has progressed after prior systemic therapy
Expanding US operations to address the increased demand for API development and manufacturing
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Zaltenibart offers best-in-class potential across multiple rare blood and kidney disorders, enhancing Novo Nordisk’s rare disease portfolio
Treatment with TUKYSA was well-tolerated, with a safety profile consistent with previously known profiles of the individual agents
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
Subscribe To Our Newsletter & Stay Updated
